Call for Papers: ADHD Across Development — Risk and Resilience Factors
- September 13, 2014: proposed submission abstract deadline
- January 11, 2015: full submission deadline
Special Issue Editors
- Co-Editor: Jeff N. Epstein
- Guest Editors: Steve S. Lee and Margaret H. Sibley
Please email an abstract (200 words or fewer) of a proposed submission by September 13, 2014.
Full submissions will be due January 11, 2015. Do not send a completed manuscript without approval of the abstract.
All submissions for the special section will go through the normal peer-review process, with no guarantee of acceptance.
All submissions must comply with APA policies, including certification of compliance with APA ethical principles for research, the prohibition of multiple submissions and duplicate publication, authors' obligation to retain raw data, and other requirements for submission to the Journal of Abnormal Psychology as noted on the Instructions to Authors.
Theme of the Special Section
A primary goal of this special section is to encourage the exploration of existing longitudinal databases to identify predictors of individual differences in the developmental course of ADHD-related symptoms, diagnostic status, comorbidities, neurobiological deficits, and functional impairments.
This special section will focus on ADHD across development. We seek manuscripts that utilize longitudinal data to test well-justified hypotheses regarding which risk and resilience factors affect the developmental trajectory of ADHD and related deficits, in addition to the mechanisms underlying these predictions. Data sets do not necessarily need to span multiple stages of development, but should include a large enough gap between assessments to inform development.
Manuscripts should address the developmental course of ADHD-related symptoms, diagnosis, comorbid diagnoses, neurobiological deficits, or impairments. Manuscripts attempting to identify predictors of the developmental course of any of these outcomes are encouraged.
Empirical manuscripts should use state-of-the-art assessment methods to measure ADHD symptoms, diagnoses, neurobiological deficits, and related impairments, as well as employ strong quantitative methods to characterize change over time. Particular attention will be paid to the methods used to define the ADHD sample.
Also, while treatments for ADHD should be taken into account as a factor that can affect the developmental trajectories of these various outcomes, ADHD treatment should not be the primary focus of the manuscript.
ADHD is a chronic condition that is discernable across the lifespan, often initially emerging in the preschool years and frequently persisting into adulthood. Several prospective longitudinal ADHD cohorts followed from childhood into adulthood along with multiple cross-sectional studies offer a basic understanding of how ADHD manifests across development.
For example, the heterotypic course of inattentive and hyperactive/impulsive ADHD symptom dimensions and the changing scope and magnitude of functional impairments across development are fairly well understood. However, there is considerable heterogeneity in ADHD-related outcomes over time. For example, diagnostically, ADHD persists beyond childhood for many whereas for others, the diagnosis desists by adolescence or adulthood. Some develop comorbid diagnoses while others do not. Neuropsychological deficits endure in some but resolve in others.
Given this highly dispersed pattern of development, there is a clear need to better understand the factors that relate to persistence and desistence of ADHD-related symptoms, diagnostic status, comorbidities, neurobiological deficits, and functional impairments over time.
Fortunately, the number of large, prospective longitudinal studies of individuals diagnosed with ADHD has multiplied over the past two decades. Some of these samples consist entirely of individuals with systematically diagnosed childhood ADHD (several of which also have matched control samples) whereas other large epidemiological studies include large numbers of individuals with documented ADHD diagnoses. These longitudinal studies often include large samples, multiple assessments, comprehensive assessment batteries, and neurobiological outcomes.